Dr Lal PathLabs on Thursday said its consolidated profit after tax declined 8 per cent to Rs 57 crore for the fourth quarter ended March 31, 2023.

The company had reported a net profit of Rs 62 crore in the January-March quarter a year ago.

Revenue from operations rose to Rs 491 crore for the fourth quarter as compared with Rs 485 crore in the year-ago period, Dr Lal PathLabs said in a regulatory filing.

For the year ended March 31, 2023, the company reported a consolidated net profit of Rs 241 crore as against Rs 350 crore in FY22.

Also read: Dr Reddy’s Labs share price outlook: Weak Revlimid sales to hurt as pharma grows; Check brokerage calls, target

The company said its board has recommended a final dividend of Rs 6 per share (60 per cent) on a face value of Rs 10 per share for the year ended March 31, 2023.

Shares of the company ended 2.21 per cent down at Rs 1,906.80 apiece on the BSE.